Innovita Biological Technology Co., Ltd. (SHA:688253)

China · Delayed Price · Currency is CNY

57.79

+0.12 (0.21%)

At close: Sep 23, 2026

Market Cap	7.79B +88.3%
Revenue (ttm)	286.33M -39.9%
Net Income	50.52M -69.5%
EPS	0.37 -69.3%
Shares Out	134.87M
PE Ratio	155.53
Forward PE	62.14
Dividend	0.45 (0.78%)
Ex-Dividend Date	Jun 16, 2026

Volume	882,975
Open	58.85
Previous Close	57.67
Day's Range	56.81 - 58.85
52-Week Range	30.00 - 73.58
Beta	1.10
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in research and development, production and sales of POCT rapid diagnostic products. It offers Covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test and TORCH test, neurological testing and hepatitis test, as well as tropical disease test such as neurological testing. The company was founded in 2006 and is based in Beijing, China. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2006

Employees 474

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688253

Full Company Profile

Financial Performance

In 2025, SHA:688253's revenue was 422.03 million, a decrease of -32.08% compared to the previous year's 621.39 million. Earnings were 144.47 million, a decrease of -41.48%.

Financial Statements